Workgroup 4: Exploration of new pathologic factors in terms of potential for prognostic significance and future applications

Cancer

Volumn 78, Issue 2, 1996, Pages 372-375

  Von Eschenbach, A C ^a   Brawer, M K ^a   Di Sant'Agnese, P A ^a   Humphrey, P A ^a   Mahran, H ^a   Murphy, G P ^a   Sebo, T J ^a   Veltri, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

APOPTOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL INTERACTION; CONFERENCE PAPER; NEOVASCULARIZATION (PATHOLOGY); NEUROSECRETORY CELL; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSRECTAL ULTRASONOGRAPHY; TUMOR GROWTH; ARTICLE; CANCER STAGING; FORECASTING; HUMAN; MALE; PATHOLOGY; PROBABILITY; PROSTATE TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

FORECASTING; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0030036082     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<372::AID-CNCR31>3.0.CO;2-R     Document Type: Conference Paper

References (0)